Tempest Therapeutics Inc.

08/12/2024 | Press release | Distributed by Public on 08/12/2024 18:34

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission
FORM 4
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response...0.5
1. Name and Address of Reporting Person *
Versant Venture Capital VI, L.P.
2. Issuer Name and Ticker or Trading Symbol
Tempest Therapeutics, Inc. [TPST]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
ONE SANSOME STREET , SUITE 1650
3. Date of Earliest Transaction (Month/Day/Year)
(Street)
SAN FRANCISCO CA 94104
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Join/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code 4. Securities Acquired (A) or Disposed of (D) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) 6. Ownership Form: Direct (D) or Indirect (I) 7. Nature of Indirect Beneficial Ownership
Code V Amount (A) or (D) Price
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code 5. Number of Derivative Securities Acquired (A) or Disposed of (D) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security 8. Price of Derivative Security 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 11. Nature of Indirect Beneficial Ownership
Code V (A) (D) Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Versant Venture Capital VI, L.P.
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Ventures VI GP, L.P.
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Ventures VI GP-GP, LLC
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Vantage II, L.P.
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Vantage II GP, L.P.
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Vantage II GP-GP, LLC
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Ventures IV, LLC
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Venture Capital IV, L.P.
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Versant Side Fund IV, L.P.
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA94104



Signatures

/s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Ventures VI GP, L.P. By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Ventures VI GP-GP, LLC By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Vantage II, L.P. By: Versant Vantage II GP, L.P. Its: General Partner By: Versant Vantage II GP-GP, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Vantage II GP, L.P. By: Versant Vantage II GP-GP, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Vantage II GP-GP, LLC By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Ventures IV, LLC By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Venture Capital IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date
/s/ Versant Side Fund IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Max Eisenberg Its: Chief Operating Officer 2024-08-12
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.35 to $1.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
(2) These shares are held of record by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
(3) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.10 to $1.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
(4) These shares are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the general partner of VVC IV and may be deemed to share voting, investment and dispositive power over the shares held by VVC IV. VV IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interests therein.
(5) These shares are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the general partner of VSF IV and may be deemed to share voting, investment and dispositive power over the shares held by VSF IV. VV IV disclaims beneficial ownership of such shares, except to the extent of its pecuniary interests therein.
(6) These shares are held of record by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the general partner of Vantage II, and Versant Vantage II GP-GP, LLC ("Vantage II GP-GP") is the general partner of Vantage II GP and each may be deemed to share voting, investment and dispositive power over the shares held by Vantage II. Each of Vantage II GP-GP and Vantage II GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.